Chimeric Therapeutics Limited is trading 5.3% down at $0.071 following a session of light, news-thin trading with no fresh company catalysts.
- Trading volume of 165,291 is currently below the 4-week average of 214,330, suggesting the move is driven by illiquidity rather than a fundamental repricing.
- The decline reinforces a pattern of recent volatility for the stock, following drops of 5.00% on June 11 and 9.09% on June 10.
- There have been no new ASX announcements or major developments reported to explain the downward movement.